On September 12, 2018, Silicon Valley-based digital manufacturing company Carbon announced the launch of its first medical-grade resin 3D printing material: Medical Polyurethane 100 (MPU 100). Similar to Carbon's rigid polyurethane material, the MPU 100 is a medical-grade, two-component resin that can be used to produce isotropic rigid plastics using Digital Light Synthesis. It is designed for use in medical systems, skin-to-skin contact devices, drug-contact devices and single-use medical device application components.

Key features of the MPU 100 include:

Engineering grade materials, With excellent wear resistance

tested in line with USP VI and ISO 10993-5 and -10 Biocompatibility

Compatible with ethylene oxide, electron beam and gamma sterilization methods

Maintains its biocompatibility after sterilization

Compatible with common disinfectants

Certificate of analysis is available

Master file

"Carbo provided by FDA n The mechanical properties, biocompatibility, sterilization compatibility and chemical resistance of the new MPU 100 resin material provide medical device manufacturers with some new capabilities to produce safe and reliable end-use products for patients." Jason Rolland, vice president at Carbon. "3D printing has great potential in the life sciences and medical device industries, and we continue to develop next-generation materials."

The MPU 100 material is currently only available in 800ML cartridges to Carbon customers in the US, Canada and Europe.

Plastic Industry Video